GenTrust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,596
Closed -$349K 208
2024
Q2
$349K Hold
3,596
0.02% 139
2024
Q1
$324K Hold
3,596
0.02% 108
2023
Q4
$287K Hold
3,596
0.02% 112
2023
Q3
$256K Hold
3,596
0.02% 118
2023
Q2
$277K Sell
3,596
-536
-13% -$41.5K 0.02% 121
2023
Q1
$311K Buy
4,132
+36
+0.9% +$2.68K 0.02% 120
2022
Q4
$323K Buy
4,096
+500
+14% +$37.5K 0.03% 108
2022
Q3
$253K Hold
3,596
0.02% 112
2022
Q2
$288K Hold
3,596
0.02% 119
2022
Q1
$273K Hold
3,596
0.02% 125
2021
Q4
$296K Buy
3,596
+300
+9% +$23.4K 0.02% 122
2021
Q3
$249K Hold
3,296
0.02% 128
2021
Q2
$268K Sell
3,296
-149
-4% -$12.2K 0.02% 122
2021
Q1
$268K Buy
+3,445
New +$270K 0.03% 108

Other funds holding CL

GenTrust's CL Position: Q3 2024 in Review

GenTrust sold out of Colgate-Palmolive (CL) in Q3 2024, closing a stake of 3,596 shares — an estimated $349K sold.

GenTrust first reported a position in CL in Q1 2021 and held it in 14 quarters. The position peaked at $349K in Q2 2024. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • GenTrust reported no remaining Colgate-Palmolive position as of Q3 2024 after selling out during the quarter.
  • GenTrust sold 3,596 Colgate-Palmolive shares in Q3 2024, an estimated $349K.
  • GenTrust first reported a position in Colgate-Palmolive in Q1 2021 and held it in 14 quarters.
  • GenTrust's Colgate-Palmolive position peaked at $349K in Q2 2024.
  • 1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on GenTrust's 13F filing for Q3 2024, filed 12 Nov 2024.